Multiple forms of cytochrome b in Mycobacterium phlei: kinetics of reduction.
The kinetics of reduction of the b-type cytochromes in the electron transport particles (ETP) from Mycobacterium phlei were studied with nicotinamide adenine dinucleotide, reduced form (NADH) or succinate as electron donors. There appeared to be three active cytochromes b in the ETP,bS563 and bS559, which were reducible by either substrate, and bN563, which was reducible by NADH but not by succinate. In the presence of adenosine 5'-triphosphate, a substantial increase in b563 reduction was observed with succinate at anaerobiosis. This was followed by a decrease in absorption. Adenosine 5'-triphosphate did not effect an increase in cytochrome b563 reduction at transition with NADH, but the occurrence of a secondary decrease in absorption was reflected in a decrease in total enzymatic reduction. The adenosine 5'-triphosphate effect was altered in trypsin-treated ETP, and abolished by uncoupling agents or by removal of the coupling factor-latent adenosine triphosphatase. In the presence of a supernatant fraction obtained during the preparation of the ETP, b563 reduction with succinate was greatly increased. A smaller increase was observed with NADH. Cytochrome b reduction was also studied in ETP inhibited by 2-n-nonylhydroxyquinoline-N-oxide, which appears to inhibit at bS563. On the basis of these data the interrelationships among the b-type cytochromes can be described in relation to the M. phlei electron transport chain.
D000251:Adenosine Triphosphatases / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000693:Anaerobiosis; D002462:Cell Membrane / Q000187:drug effects; D003580:Cytochromes / Q000032:analysis / Q000378:metabolism*; D004579:Electron Transport / Q000187:drug effects; D006912:Hydroxyquinolines / Q000494:pharmacology; D007700:Kinetics; D008954:Models, Biological; D009161:Mycobacterium / Q000378:metabolism*; D009168:Mycobacterium phlei / Q000378:metabolism*; D009243:NAD / Q000378:metabolism; D010087:Oxides; D013386:Succinates / Q000378:metabolism; D014357:Trypsin / Q000494:pharmacology; D014475:Uncoupling Agents / Q000494:pharmacology
D003580:Cytochromes; D006912:Hydroxyquinolines; D010087:Oxides; D013386:Succinates; D014475:Uncoupling Agents; D009243:NAD; D000255:Adenosine Triphosphate; D014357:Trypsin; D000251:Adenosine Triphosphatases